Ledger.Open graph →
SEC Form D · filed September 21, 2021

bluebird bio, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Mark R. Vachon · Cambridge, MADirectorRamy S. Ibrahim · Cambridge, MADirectorMark R. Vachon · Cambridge, MADirectorJason Cole · Cherry Hill, NJExecWilliam R. Sellers · Cambridge, MADirectorRamy S. Ibrahim · Cambridge, MADirectorDenice R. Torres · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorDaniel S. Lynch · Stamford, CTDirectorChip Baird · Redding, CAExecWendy S. Dixon · Cambridge, MADirectorJason Cole · Cambridge, MAExecJohn S. Agwunobi · Cambridge, MADirectorNick S. Leschly · Cambridge, MAExec · DirectorNick S. Leschly · Cambridge, MAExec · DirectorDenice R. Torres · Cambridge, MADirectorWilliam R. Sellers · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorWendy S. Dixon · Cambridge, MADirectorChip Baird · New York, NYExecJohn S. Agwunobi · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗